AIM Stock Analysis: Buy, Sell, or Hold?
AIM - AIM ImmunoTech Inc.
$0.73
-0.09 (-11.46%)
▼
5d:
+82.5%
30d:
+41.7%
90d:
+5.96%
WAIT
LOW Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 21, 2026
0d
Get Alerted When AIM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
25 traders called AIM this week
99% bullish • 1 bearish
99% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: AIM is 20.0% above its trading range ($0.61). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: AIM is 20.0% above its trading range ($0.61). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: AIM is currently trading at $0.73, which is considered extended relative to its 30-day fair value range of $0.27 to $0.61.
Technical Outlook: Technically, AIM is in a strong downtrend. Immediate support is located at $0.21, while resistance sits at $1.25. Short-term momentum is weak, with the stock down 11.5% recently.
Market Sentiment: AIM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.25 (+617.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AIM is in a strong downtrend. Immediate support is located at $0.21, while resistance sits at $1.25. Short-term momentum is weak, with the stock down 11.5% recently.
Market Sentiment: AIM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.25 (+617.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.27 -
$0.61
Company Quality Score
60/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
42.1%
All Signals
- BEARISH: Price significantly overextended (+20.0% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BEARISH: Downward momentum (-11.5%)
- BULLISH: Trading 617.2% below Wall St target ($5.25)
Trading Range Analysis
30-Day Trading Range
$0.27 -
$0.61
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.21
Resistance Level
$1.25
Current Trend
Strong Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.41
Wall Street Target
$5.25
(+617.2%)
Revenue Growth (YoY)
-53.3%
Share & Embed Analysis
Last updated: June 04, 2026 5:22 AM ET
Data refreshes hourly during market hours. Next update: 6:22 AM
Data refreshes hourly during market hours. Next update: 6:22 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AIM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 54 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 62 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$123 | 50 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 52 HOLD |
